Development of a metastatic fluorescent Lewis Lung carcinoma mouse model: Identification of mRNAs and microRNAs involved in tumor invasion

Gene

Volumn 517, Issue 1, 2013, Pages 72-81

  Rask, Lene ^a,b   Fregil, Marianne ^a   Høgdall, Estrid ^a   Mitchelmore, Cathy ^c   Eriksen, Jens ^a,d  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c ROSKILDE UNIVERSITY   (Denmark)

^d NAESTVED HOSPITAL   (Denmark)

Author keywords

Lewis Lung carcinoma; Matrix metalloproteinases; Metastasis; MicroRNA; MiR 203; MiR 9

Indexed keywords

COLLAGENASE 3; GELATINASE A; MESSENGER RNA; MICRORNA; MICRORNA 126; MICRORNA 140; MICRORNA 146A; MICRORNA 150; MICRORNA 196; MICRORNA 203; MICRORNA 218; MICRORNA 9; PROTEIN KINASE SYK; RED FLUORESCENT PROTEIN; SCATTER FACTOR; STROMELYSIN; STROMELYSIN 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CELL LINE; DOWN REGULATION; FEMALE; IN VIVO STUDY; LEWIS CARCINOMA; LUNG METASTASIS; METASTASIS; MICRORNA 184; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRENATAL DIAGNOSIS; PRIMARY TUMOR; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CARCINOMA, LEWIS LUNG; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; LUNG NEOPLASMS; MICE; MICE, INBRED C57BL; MICRORNAS; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

MUS;

EID: 84873526413     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.12.083     Document Type: Article

References (59)

1. Barbarotto E., Schmittgen T.D., Calin G.A. MicroRNAs and cancer: profile, profile, profile. Int. J. Cancer 2008, 122:969-977.
2. Benjamini Y., Drai D., Elmer G., Kafkafi N., Golani I. Controlling the false discovery rate in behavior genetics research. Behav. Brain Res. 2001, 125:279-284.
3. Bo J. microRNA-203 suppresses bladder cancer development by repressing bcl-w expression. FEBS J. 2011, 278:786-792.
4. Bobek V., et al. Syngeneic lymph-node-targeting model of green fluorescent protein-expressing Lewis lung carcinoma. Clin. Exp. Metastasis 2004, 21:705-708.
5. Cecchi F., Rabe D.C., Bottaro D.P. Targeting the HGF/Met signalling pathway in cancer. Eur. J. Cancer 2010, 46:1260-1270.
6. Chiosea S., et al. Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma. Am. J. Pathol. 2006, 169:1812-1820.
7. Coopman P.J., Mueller S.C. The Syk tyrosine kinase: a new negative regulator in tumor growth and progression. Cancer Lett. 2006, 241:159-173.
8. Croce C.M. Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet. 2009, 10:704-714.
9. Deliolanis N.C., Kasmieh R., Wurdinger T., Tannous B.A., Shah K., Ntziachristos V. Performance of the red-shifted fluorescent proteins in deep-tissue molecular imaging applications. J. Biomed. Opt. 2008, 13:044008.
10. Diaz R., et al. Deregulated expression of miR-106a predicts survival in human colon cancer patients. Genes Chromosomes Cancer 2008, 47:794-802.
11. Dieguez-Hurtado R., et al. A Cre-reporter transgenic mouse expressing the far-red fluorescent protein Katushka. Genesis 2011, 49:36-45.
12. Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2002, 2:161-174.
13. Feber A., et al. MicroRNA expression profiles of esophageal cancer. J. Thorac. Cardiovasc. Surg. 2008, 135:255-260.
14. Ferretti E., et al. MicroRNA profiling in human medulloblastoma. Int. J. Cancer 2009, 124:568-577.
15. Furuta M., Kozaki K.I., Tanaka S., Arii S., Imoto I., Inazawa J. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 2010, 31:766-776.
16. Geiger T.R., Peeper D.S. Metastasis mechanisms. Biochim. Biophys. Acta 2009, 1796:293-308.
17. Griffiths-Jones S., Saini H.K., van Dongen S., Enright A.J. miRBase: tools for microRNA genomics. Nucleic Acids Res. 2008, 36:D154-D158.
18. Guled M., et al. CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma-a miRNA microarray analysis. Genes Chromosomes Cancer 2009, 48:615-623.
19. Gupta G.P., Massague J. Cancer metastasis: building a framework. Cell 2006, 127:679-695.
20. Gururajan M., et al. Spleen tyrosine kinase (Syk), a novel target of curcumin, is required for B lymphoma growth. J. Immunol. 2007, 178:111-121.
21. Hildebrandt M.A., et al. Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma. Oncogene 2010, 29:5724-5728.
22. Hoffman R.M. A better fluorescent protein for whole-body imaging. Trends Biotechnol. 2008, 26:1-4.
23. Huang W., Li M.D. Nicotine modulates expression of miR-140*, which targets the 3'-untranslated region of dynamin 1 gene (Dnm1). Int. J. Neuropsychopharmacol. 2009, 12:537-546.
24. Ikenaga N., et al. MicroRNA-203 expression as a new prognostic marker of pancreatic adenocarcinoma. Ann. Surg. Oncol. 2010, 17:3120-3128.
25. Islekel H., Oktay G., Terzi C., Canda A.E., Fuzun M., Kupelioglu A. Matrix metalloproteinase-9,-3 and tissue inhibitor of matrix metalloproteinase-1 in colorectal cancer: relationship to clinicopathological variables. Cell Biochem. Funct. 2007, 25:433-441.
26. Karube Y., et al. Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci. 2005, 96:111-115.
27. Kishi Y., et al. Systemic NK4 gene therapy inhibits tumor growth and metastasis of melanoma and lung carcinoma in syngeneic mouse tumor models. Cancer Sci. 2009, 100:1351-1358.
28. Kominsky S.L., Doucet M., Thorpe M., Weber K.L. MMP-13 is over-expressed in renal cell carcinoma bone metastasis and is induced by TGF-beta1. Clin. Exp. Metastasis 2008, 25:865-870.
29. Kumar M.S., Lu J., Mercer K.L., Golub T.R., Jacks T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat. Genet. 2007, 39:673-677.
30. Lin R.J., et al. microRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastoma. Cancer Res. 2010, 70:7841-7850.
31. Liu S.Y., Liu Y.C., Huang W.T., Huang G.C., Su H.J., Lin M.H. Requirement of MMP-3 in anchorage-independent growth of oral squamous cell carcinomas. J. Oral Pathol. Med. 2007, 36:430-435.
32. Lu J., et al. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838.
33. Ma L., et al. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat. Cell Biol. 2010, 12:247-256.
34. Mukherjee S., et al. Increased matrix metalloproteinase activation in esophageal squamous cell carcinoma. J. Transl. Med. 2010, 8:91.
35. Muralidhar B., et al. Global microRNA profiles in cervical squamous cell carcinoma depend on Drosha expression levels. J. Pathol. 2007, 212:368-377.
36. Papadopoulos G.L., Alexiou P., Maragkakis M., Reczko M., Hatzigeorgiou A.G. DIANA-mirPath: integrating human and mouse microRNAs in pathways. Bioinformatics 2009, 25:1991-1993.
37. Pardo A., et al. In vivo imaging of immunotoxin treatment using Katushka-transfected A-431 cells in a murine xenograft tumour model. Cancer Immunol. Immunother. 2012, 61:1617-1626.
38. Passlick B., et al. Overexpression of matrix metalloproteinase 2 predicts unfavorable outcome in early-stage non-small cell lung cancer. Clin. Cancer Res. 2000, 6:3944-3948.
39. Petrovsky A., Schellenberger E., Josephson L., Weissleder R., Bogdanov A. Near-infrared fluorescent imaging of tumor apoptosis. Cancer Res. 2003, 63:1936-1942.
40. Prontera C., Mariani B., Rossi C., Poggi A., Rotilio D. Inhibition of gelatinase A (MMP-2) by batimastat and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma. Int. J. Cancer 1999, 81:761-766.
41. Rashidi B., et al. A highly metastatic Lewis lung carcinoma orthotopic green fluorescent protein model. Clin. Exp. Metastasis 2000, 18:57-60.
42. Rodriguez A., Griffiths-Jones S., Ashurst J.L., Bradley A. Identification of mammalian microRNA host genes and transcription units. Genome Res. 2004, 14:1902-1910.
43. Saito Y., Friedman J.M., Chihara Y., Egger G., Chuang J.C., Liang G. Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells. Biochem. Biophys. Res. Commun. 2009, 379:726-731.
44. Shcherbo D., et al. Bright far-red fluorescent protein for whole-body imaging. Nat. Methods 2007, 4:741-746.
45. Stormes K.A., Lemken C.A., Lepre J.V., Marinucci M.N., Kurt R.A. Inhibition of metastasis by inhibition of tumor-derived CCL5. Breast Cancer Res. Treat. 2005, 89:209-212.
46. Talvensaari-Mattila A., Paakko P., Turpeenniemi-Hujanen T. Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma. Br. J. Cancer 2003, 89:1270-1275.
47. Tan H.X., et al. MicroRNA-9 reduces cell invasion and E-cadherin secretion in SK-Hep-1 cell. Med. Oncol. 2010, 27:654-660.
48. Tang C.H., Yamamoto A., Lin Y.T., Fong Y.C., Tan T.W. Involvement of matrix metalloproteinase-3 in CCL5/CCR5 pathway of chondrosarcomas metastasis. Biochem. Pharmacol. 2010, 79:209-217.
49. Van T.C., Potworowski E.F., St-Pierre Y. Stromelysin-1 (MMP-3) is inducible in T lymphoma cells and accelerates the growth of lymphoid tumors in vivo. Biochem. Biophys. Res. Commun. 2004, 315:884-891.
50. Viticchie G., et al. MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines. Cell Cycle 2011, 10:1121-1131.
51. Wan H.Y., Guo L.M., Liu T., Liu M., Li X., Tang H. Regulation of the transcription factor NF-kappaB1 by microRNA-9 in human gastric adenocarcinoma. Mol. Cancer 2010, 9:16.
52. Wang L., et al. Matrix metalloproteinase 2 (MMP2) and MMP9 secreted by erythropoietin-activated endothelial cells promote neural progenitor cell migration. J. Neurosci. 2006, 26:5996-6003.
53. Winter J., Jung S., Keller S., Gregory R.I., Diederichs S. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat. Cell Biol. 2009, 11:228-234.
54. Wossning T., et al. Deregulated Syk inhibits differentiation and induces growth factor-independent proliferation of pre-B cells. J. Exp. Med. 2006, 203:2829-2840.
55. Yap T.A., de Bono J.S. Targeting the HGF/c-Met axis: state of play. Mol. Cancer Ther. 2010, 9:1077-1079.
56. Young R.M., et al. Mouse models of non-Hodgkin lymphoma reveal Syk as an important therapeutic target. Blood 2009, 113:2508-2516.
57. Zhang Q., Furukawa K., Chen H.H., Sakakibara T., Urano T., Furukawa K. Metastatic potential of mouse Lewis lung cancer cells is regulated via ganglioside GM1 by modulating the matrix metalloprotease-9 localization in lipid rafts. J. Biol. Chem. 2006, 281:18145-18155.
58. Zhang H., Li Y., Lai M. The microRNA network and tumor metastasis. Oncogene 2010, 29:937-948.
59. Zigrino P., et al. Stromal expression of MMP-13 is required for melanoma invasion and metastasis. J. Invest Dermatol. 2009, 129:2686-2693.